PE/Cyanine7 anti-mouse Ly-6C Antibody

Product Details

Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

L3 cloned CTL cells

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)

Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C5⁸.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells^1-3 and immunohistochemistry of frozen sections⁴.

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed

Product Citations

1. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
2. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
3. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
4. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
5. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
6. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
7. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
8. Wu W, et al. 2018. J Am Soc Nephrol. 29:168. PubMed
9. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
10. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
11. Pascual–García M, et al. 2019. Nat Commun. 10:2416. PubMed
12. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
13. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
14. Albarrán–Juárez J, et al. 2018. J Exp Med. 215:2655. PubMed
15. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
16. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
17. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
18. Zhang J, et al. 2020. Cell Metabolism. 31(6):1136-1153. PubMed
19. Rasid O, et al. 2020. Cell Reports. 29(12):3933-3945.e3.. PubMed
20. Weinstock NI, et al. 2020. Neuron. 107(1):65-81. PubMed
21. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
22. Paubelle E, et al. 2020. Cell Reports. 30(3):739-754.e4.. PubMed
23. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
24. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
25. Clement M, et al. 2014. Proc Natl Acad Sci U S A. 111:1101. PubMed
26. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
27. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
28. Molina M, et al. 2015. PLoS One. 10:127262. PubMed
29. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
30. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
31. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
32. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
33. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
34. Moyat M, et al. 2015. Infect Immun . 83: 4217 - 4228. PubMed
35. Dudek M, et al. 2015. Mucosal Immunol. . PubMed
36. Steiger S, et al. 2015. J Immunol. 195: 5495 - 5502. PubMed
37. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
38. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
39. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
40. Saha S, et al. 2016. Nat Commun. 7:13096. PubMed
41. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
42. Geng S, et al. 2016. Nat Commun. 7:13436. PubMed
43. Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
44. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
45. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
46. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
47. Runyan CE, et al. 2020. Aging Cell. 19:00. PubMed
48. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
49. Nakayama Y, et al. 2020. Proc Natl Acad Sci U S A. 117:14365. PubMed
50. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
51. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
52. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
53. Tang CC, et al. 2021. eLife. 10:00. PubMed
54. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
55. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
56. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
57. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
58. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
59. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
60. Liu SS, et al. 2021. Immunity. :. PubMed
61. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
62. Kleinholz CL, et al. 2021. Sci Rep. 11:15071. PubMed
63. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
64. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
65. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
66. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
67. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
68. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
69. Iizasa E, et al. 2021. Nat Commun. 12:2299. PubMed
70. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
71. Geng S, et al. 2021. JCI Insight. 6:. PubMed
72. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
73. Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed
74. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
75. Brandt S, et al. 2020. J Am Soc Nephrol. 31:2589. PubMed
76. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
77. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
78. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
79. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
80. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
81. Souza SP, et al. 2021. PLoS Pathog. 17:e1010081. PubMed
82. Warheit-Niemi HI, et al. 2022. JCI Insight. 7:. PubMed
83. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
84. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
85. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
86. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
87. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
88. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
89. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
90. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
91. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
92. Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
93. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
94. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
95. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
96. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
97. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
98. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
99. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
100. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
101. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
102. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
103. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
104. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
105. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
106. Boroumand P, et al. 2022. Elife. 11:. PubMed
107. Li J, et al. 2022. Elife. 11:. PubMed
108. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
109. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
110. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed

RRID

AB_1732093 (BioLegend Cat. No. 128017)
AB_1732082 (BioLegend Cat. No. 128018)

Antigen Details

Structure

14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.

Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8⁺ T cells.

Cell Type

Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells

Biology Area

Immunology

Molecular Family

CD Molecules

Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID

17067 View all products for this Gene ID

UniProt

View information about Ly-6C on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Concentration & Expiration Lookup

Certificate of Analysis